Thijs, Liselot http://orcid.org/0000-0003-4692-2230
Voets, Eline
Wiskerke, Evelien
Nauwelaerts, Thomas
Arys, Yves
Haspeslagh, Harold
Kool, Jan
Bischof, Patrick
Bauer, Christoph
Lemmens, Robin
Baumgartner, Daniel
Verheyden, Geert
Funding for this research was provided by:
Eurostars (E! 11323, E! 11323, E! 11323, E! 11323)
Stiftelsen Promobilia (Ref. 20062)
Article History
Received: 18 March 2021
Accepted: 13 July 2021
First Online: 28 July 2021
Declarations
:
: Ethische Toestingscommissie Jessa Ziekenhuis, Belgian registration number; B2432020000014, all participants gave written informed consent.
: Not applicable.
: LT, EV, EW, JK, TN, PB, CB declared no competing interest. GV and DB received Eurostars funding (Project ID 11323) as academic partners in the project, GV received Promobilia funding (Ref. 20062) for conducting this clinical trial. DB, YA and HH received Eurostars funding (Project ID 11323) as industrial partners in the project. DB, YA, HH declared holding stocks or shares in an organization that may in any way gain or lose financially from the publication of the manuscript, either now or in the future and receiving reimbursements, fees, funding, or salary from an organization that holds or has applied for patents relating to the content of the manuscript.